Imunon Inc (IMNN) Q4 2024 Earnings Call Highlights: Promising Advances Amid Financial Challenges
Imunon Inc (NASDAQ:IMNN) announced positive results from their phase 2 Ovation 2 study, showing significant improvement in ...
Q4 2024 Imunon Inc Earnings Call
Stacy Lindborg; Independent Director; Imunon Inc. Presentation. Operator. Good morning. My name is Mike, and I will be your operator today. At this time, I would lik ...
IMUNON Reports 2024 Financial Results and Provides Business Update Highlighting Significant Progress Towards the Initiation of a Pivotal Phase 3 Study
IMNN-001 remains the first immunotherapy to achieve a meaningful overall survival benefit in advanced ovarian cancer Patient enrollment in Phase ...
Imunon, Inc. (IMNN) Q4 2024 Earnings Call Transcript
Q4 2024 Results Conference Call February 26, 2025 11:00 AM ETCompany ParticipantsPeter Vozzo - ICR Healthcare, IRStacy Lindborg ...
Imunon reports 2024 EPS ($1.62) vs. ($2.16) last year
Ended 2024 with $5.9M in cash and cash equivalents. The company believes it has sufficient capital resources to fund its operations into late ...
manilatimes20h
Form 8.3 - AXA INVESTMENT MANAGERS: Direct Line Insurance Group plc
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant ...